MBCL-52. ENDOCRINE PROFILE AFTER MEDULLOBLASTOMA TREATMENT

BACKGROUND: Treatment of medulloblastoma has evolved substantially with more chemotherapy, risk-adapted dosing of radiotherapy (RT) and new RT techniques. We present the endocrine profile for our patients treated over a 20-year period. METHODS: The charts of patients treated for medulloblastoma betw...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Pavon-Mengual, Miriam, Curry, Helen, Saraff, Vrinda, Mohamed, Zainaba, Benghiat, Helen, Ford, Daniel, Peet, Andrew, Adamski, Jenny, English, Martin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Medulloblastoma (Clinical)
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715513/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.521
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller